Category: Diseases & Conditions
Europe Diseases & Conditions
-
Laparoscopic Devices Market Size, Share & Trends Analysis - Europe - 2023-2029 - MedSuite - Includes: Laparoscopes, Access Devices, Closure Devices, and 9 more
... with strong market shares. This comprehensive market analysis reviewed over 55 companies across Europe, employing in-depth methodologies to assess market size, unit sales, and company shares while also developing reliable forecasts. The European laparoscopic device ... Read More
-
US and Europe Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral Vectors and Non-Viral Vectors)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Country
... Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Country The US and Europe cell and gene therapy manufacturing services market was valued at ... Read More
-
Europe Insulin Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 7.20 billion by 2028, growing at a CAGR of 4.89% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the European Insulin Drugs Market. Type-1 diabetes patients are impacted more during Covid-19. ... Read More
-
United Kingdom Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... in 2023 to USD 1.09 billion by 2028, at a CAGR of 6.72% during the forecast period (2023-2028). The COVID-19 pandemic had a substantial impact on the United Kingdom's diabetes care devices. According to The ... Read More
-
Europe Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 8.41 billion by 2028, at a CAGR of 3.40% during the forecast period (2023-2028). The COVID-19 epidemic significantly influenced the European Diabetes Medicines Market. As people with diabetes already have weakened immune systems, COVID-19 ... Read More
-
Spain Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 1.45 billion by 2028, growing at a CAGR of 4.50% during the forecast period (2023-2028). Spain has According to WHO, 102,258,825 vaccination doses have been delivered as of June 25, 2022. Regardless ... Read More
-
Spain Insulin Drugs And Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023, and is expected to reach USD 383.05 million by 2028, growing at a CAGR of 1.80% during the forecast period (2023-2028). One of the most significant risk factors for a severe course of COVID-19 ... Read More
-
Spain Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 948 million by 2028, growing at a CAGR of 7.41% during the forecast period (2023-2028). In Sapin According to WHO, as of 25 June 2022, a total of 102,258,825 vaccine doses have been administered. ... Read More
-
Europe Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 10.21 billion by 2028, at a CAGR of 6.18% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the Europe Diabetes Care Devices Market. People with diabetes have a weak immune system ... Read More
-
Europe Insulin Infusion Pumps Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 650.23 million by 2028, growing at a CAGR of 3.85% during the forecast period (2023-2028). The COVID-19 pandemic has had a significant impact on the market studied. Type-1 diabetes patients have been ... Read More
-
France Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion by 2028, at a CAGR of 3.22% during the forecast period (2023-2028). One of the most significant risk factors for a severe course of COVID-19 is diabetes mellitus. This risk is believed to be ... Read More
-
Europe Insulin Syringe Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 117.35 million by 2028, growing at a CAGR of 1.20% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the Europe Insulin Syringe Market. People with diabetes have a weak immune system ... Read More
-
Italy Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 1.27 billion by 2028, growing at a CAGR of 6.70% during the forecast period (2023-2028). Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly ... Read More
-
Germany Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion by 2028, at a CAGR of 3.47% during the forecast period (2023-2028). Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Most people ... Read More
-
France Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 1.68 billion by 2028, growing at a CAGR of 6.58% during the forecast period (2023-2028). One of the most significant risk factors for a severe course of COVID-19 is diabetes mellitus. This risk is ... Read More
-
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GlL[-1) Receptor Agonist Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... size is expected to grow from USD 9.20 billion in 2023 to USD 11.52 billion by 2028, at a CAGR of 4.61% during the forecast period (2023-2028). The COVID-19 epidemic has significantly affected the market ... Read More
-
United Kingdom (UK) Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 1.20 billion by 2028, at a CAGR of 3.05% during the forecast period (2023-2028). The COVID-19 pandemic has had a substantial impact on the United Kingdom's diabetes drugs market. According to The British Diabetic ... Read More
-
Europe Insulin Pens Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 2.29 billion by 2028, growing at a CAGR of 1.45% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the European Insulin Pens Market. Type-1 diabetes patients are impacted more during Covid-19. ... Read More
-
Italy Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 809.55 million by 2028, at a CAGR of 3.50% during the forecast period (2023-2028). The COVID-19 pandemic caused early fatalities during the first year of its existence, primarily in older people. The first nation ... Read More
-
Italy Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion by 2028, at a CAGR of 3% during the forecast period (2023-2028). Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Italy was ... Read More
-
Intractable Focal Epilepsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Elevating Neurological Care for Intractable Focal Epilepsy The global intractable focal epilepsy treatment market is gaining significant traction as a critical field within neurology, focusing on tackling persistent focal seizures that resist conventional medications. This ... Read More
-
Europe Biosimilars Market Forecast to 2030 - Regional Analysis By Disease Indication (Cancer, Diabetes, Autoimmune Disease, and Other Disease Indication), Route of Administration (Intravenous, Subcutaneous, and Others), Drug Class (Granulocyte Colony-Stimulating Factor, Insulin, TNF Blockers and Monoclonal Antibodies, and Others), Distribution Channel (Hospital Pharmacies, Compounding Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region
... and Monoclonal Antibodies, and Others), Distribution Channel (Hospital Pharmacies, Compounding Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region The Europe biosimilars market is expected to grow from US$ 10,344.86 million in 2022 to US$ 1,15,125.91 ... Read More
-
Residential Mental Health and Substance Abuse Facilities - 2023 U.S. Market Research Report with Updated COVID-19 & Potential Recession Forecasts
... of the most comprehensive and in-depth assessments of the industry in the United States with over 100+ data sets covering 2014-2027. This Kentley Insights report is full of industry insights including historical and forecasted market ... Read More
-
Spain Self Diagnostics Market
... Pharmacies, Hospital Pharmacies, Hypermarket/Supermarket, E-Commerce Channels/Online Pharmacies), By Region, Competition Forecast, and Opportunities, 2028 Spain self diagnostics market is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028. The self diagnostics ... Read More
-
Europe Hydrolyzed Collagen Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Source (Bovine, Porcine, Poultry, Marine, and Others) and Application (Food and Beverages, Pharmaceuticals and Nutraceuticals, Personal Care, and Others)
... Europe hydrolyzed collagen market was valued at US$ 248.98 million in 2022 and is expected to reach US$ 343.79 million by 2028; it is estimated to grow at a CAGR of 5.5% from 2022 to ... Read More
Research Assistance
